Stock, pipeline and biotech catalyst intelligence
Clinical portfolio
| Asset | Indication | Stage | Milestone | Signals ? |
|---|---|---|---|---|
| OJEMDA™ (Tovorafenib) (DAY101) | Cancer, Pediatric low-grade glioma | Phase 3 | Aug 15, 2027 | — |
| Emi-Le/Emiltatug Ledadotin (Emi-Le) (B7-H4 ADC) | Cancer, Adenoid Cystic Carcinoma | Phase 1 | Aug 31, 2026 | — |
| DAY301 (formerly MTX-13) | Solid tumor/s | Phase 1a | Dec 31, 2026 | — |
Upcoming milestones
Company profile
Day One Pharmaceuticals is a biotechnology company in the healthcare sector.
Company profile compiled from available company records. Catalyst dates can change and should be confirmed against the linked primary source.
Page updated Aug 23, 2026 · Yahoo quotes cached for one minute; reference data may be used when a live field is unavailable.
Cancer, Adenoid Cystic Carcinoma
Data readoutSolid tumor/s
Data readout